Your browser is no longer supported. Please, upgrade your browser.
EW [NYSE]
Edwards Lifesciences Corporation
IndexS&P 500 P/E50.45 EPS (ttm)2.31 Insider Own0.20% Shs Outstand622.30M Perf Week3.95%
Market Cap72.29B Forward P/E45.03 EPS next Y2.59 Insider Trans-25.40% Shs Float618.72M Perf Month-3.66%
Income1.46B PEG3.13 EPS next Q0.54 Inst Own86.90% Short Float0.98% Perf Quarter7.07%
Sales4.93B P/S14.68 EPS this Y-21.00% Inst Trans0.17% Short Ratio2.93 Perf Half Y21.41%
Book/sh8.25 P/B14.13 EPS next Y14.36% ROA20.20% Target Price119.36 Perf Year46.88%
Cash/sh2.52 P/C46.31 EPS next 5Y16.11% ROE31.50% 52W Range70.92 - 123.27 Perf YTD27.80%
Dividend- P/FCF68.79 EPS past 5Y11.70% ROI15.60% 52W High-5.42% Beta1.01
Dividend %- Quick Ratio2.90 Sales past 5Y12.00% Gross Margin75.50% 52W Low64.40% ATR2.56
Employees14900 Current Ratio3.70 Sales Q/Q48.80% Oper. Margin33.20% RSI (14)58.36 Volatility1.84% 2.20%
OptionableYes Debt/Eq0.12 EPS Q/Q495.40% Profit Margin29.70% Rel Volume0.94 Prev Close115.74
ShortableYes LT Debt/Eq0.12 EarningsOct 27 AMC Payout0.00% Avg Volume2.08M Price116.59
Recom2.20 SMA204.01% SMA500.52% SMA20017.77% Volume1,954,479 Change0.73%
Jul-30-21Reiterated Wells Fargo Equal Weight $93 → $115
Jul-30-21Reiterated UBS Neutral $98 → $115
Jul-30-21Reiterated Stifel Buy $103 → $120
Jul-30-21Reiterated Oppenheimer Outperform $97 → $120
Jul-30-21Reiterated Morgan Stanley Overweight $108 → $135
Jul-30-21Reiterated Jefferies Buy $110 → $130
Jul-30-21Reiterated Deutsche Bank Hold $84 → $113
Jul-30-21Reiterated Canaccord Genuity Buy $103 → $124
May-25-21Initiated Barclays Overweight $110
Apr-15-21Initiated Atlantic Equities Neutral $85
Apr-05-21Upgrade Evercore ISI In-line → Outperform
Dec-16-20Downgrade Citigroup Buy → Neutral $97
Dec-11-20Reiterated Canaccord Genuity Buy $89 → $94
Sep-11-20Initiated Wolfe Research Underperform
Apr-28-20Downgrade Wells Fargo Overweight → Equal Weight $250 → $230
Apr-17-20Upgrade SVB Leerink Mkt Perform → Outperform $270
Mar-05-20Initiated Citigroup Buy $252
Feb-13-20Initiated Goldman Neutral $253
Feb-06-20Resumed BTIG Research Neutral
Jan-10-20Initiated Oppenheimer Outperform $280
Oct-20-21 07:05AM  
Oct-19-21 11:40AM  
Oct-18-21 08:57AM  
Oct-15-21 02:49PM  
01:23PM  
Oct-14-21 09:04AM  
08:20AM  
Oct-13-21 03:01PM  
Oct-12-21 09:10AM  
Oct-07-21 07:31AM  
Oct-04-21 11:16AM  
Sep-14-21 03:04PM  
Aug-23-21 07:34AM  
Aug-19-21 09:26AM  
06:20AM  
Aug-18-21 02:00PM  
Aug-04-21 01:21PM  
Aug-02-21 09:54AM  
Jul-31-21 05:02AM  
Jul-30-21 09:41AM  
08:13AM  
06:32AM  
Jul-29-21 05:55PM  
04:23PM  
04:15PM  
11:13AM  
Jul-28-21 09:22AM  
Jul-23-21 07:05AM  
Jul-22-21 03:15PM  
07:05AM  
06:20AM  
Jul-19-21 01:26PM  
Jul-15-21 03:01PM  
Jul-03-21 04:25AM  
Jun-29-21 08:33AM  
Jun-24-21 04:48PM  
Jun-22-21 05:31PM  
Jun-15-21 01:52PM  
Jun-14-21 07:26AM  
Jun-07-21 02:24AM  
Jun-01-21 04:15PM  
May-20-21 11:30AM  
May-18-21 04:15PM  
04:15PM  
May-14-21 05:37PM  
May-12-21 02:16AM  
May-07-21 02:54PM  
May-05-21 09:15AM  
Apr-22-21 02:00AM  
Apr-21-21 04:21PM  
03:00PM  
10:03AM  
08:17AM  
08:08AM  
Apr-20-21 10:00PM  
05:45PM  
05:20PM  
04:15PM  
Apr-19-21 11:28AM  
Apr-15-21 03:32AM  
Apr-14-21 12:53PM  
Apr-13-21 12:30PM  
09:47AM  
07:05AM  
Apr-09-21 04:05PM  
Apr-01-21 04:46PM  
Mar-29-21 01:14PM  
Mar-20-21 04:57AM  
Mar-10-21 05:20AM  
Mar-02-21 05:00AM  
Feb-21-21 11:49PM  
Jan-31-21 04:51PM  
Jan-30-21 02:41AM  
Jan-28-21 08:08AM  
Jan-27-21 09:01PM  
05:35PM  
05:16PM  
04:50PM  
04:15PM  
03:15PM  
07:35AM  
Jan-26-21 10:32AM  
Jan-20-21 11:52AM  
Jan-14-21 07:53AM  
Jan-13-21 07:05AM  
Jan-08-21 04:25PM  
Dec-23-20 01:08AM  
Dec-21-20 09:05AM  
Dec-18-20 01:28PM  
Dec-14-20 07:58PM  
10:51AM  
Dec-10-20 09:05AM  
Dec-03-20 12:07AM  
Nov-24-20 09:49AM  
Nov-17-20 04:44PM  
Nov-13-20 06:20AM  
Oct-26-20 10:04PM  
Oct-23-20 06:45AM  
Oct-22-20 09:30AM  
07:52AM  
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Szyman Catherine M.CVP, Critical CareOct 18Option Exercise21.769,741211,96437,156Oct 18 05:00 PM
Szyman Catherine M.CVP, Critical CareOct 18Sale110.419,7411,075,48227,415Oct 18 05:00 PM
Wood Larry LCVP, TAVROct 11Option Exercise35.207,830275,590379,964Oct 12 04:51 PM
Wood Larry LCVP, TAVROct 11Sale108.007,830845,640372,134Oct 12 04:51 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 08Option Exercise21.7611,050240,44867,449Oct 08 05:03 PM
WANG HUIMINCVP, Japan & IntercontinentalOct 08Option Exercise21.766,350138,176104,377Oct 08 05:03 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 08Sale110.4911,0501,220,88156,399Oct 08 05:03 PM
WANG HUIMINCVP, Japan & IntercontinentalOct 08Sale110.916,350704,27898,027Oct 08 05:03 PM
MUSSALLEM MICHAEL AChairman & CEOOct 01Option Exercise21.7645,050980,288233,052Oct 01 09:06 PM
MUSSALLEM MICHAEL AChairman & CEOOct 01Sale111.7232,5503,636,375188,002Oct 01 09:06 PM
MUSSALLEM MICHAEL AChairman & CEOSep 15Option Exercise21.7645,050980,288233,052Sep 16 04:07 PM
MUSSALLEM MICHAEL AChairman & CEOSep 15Sale121.1732,5503,944,202188,002Sep 16 04:07 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 10Option Exercise21.7611,050240,44867,449Sep 10 08:28 PM
Wood Larry LCVP, TAVRSep 10Option Exercise35.207,830275,590379,964Sep 10 08:28 PM
Wood Larry LCVP, TAVRSep 10Sale122.597,830959,880372,134Sep 10 08:28 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 10Sale122.2511,0501,350,87556,399Sep 10 08:28 PM
Szyman Catherine M.CVP, Critical CareSep 08Option Exercise21.769,741211,96437,156Sep 08 09:04 PM
WANG HUIMINCVP, Japan & IntercontinentalSep 08Option Exercise21.766,350138,176104,377Sep 08 09:04 PM
Szyman Catherine M.CVP, Critical CareSep 08Sale121.289,7411,181,36227,415Sep 08 09:04 PM
WANG HUIMINCVP, Japan & IntercontinentalSep 08Sale121.256,350769,94798,027Sep 08 09:04 PM
Wood Larry LCVP, TAVRAug 10Option Exercise35.207,830275,590379,964Aug 10 09:24 PM
Wood Larry LCVP, TAVRAug 10Sale114.147,830893,678372,134Aug 10 09:24 PM
WANG HUIMINCVP, Japan & IntercontinentalAug 09Option Exercise21.766,350138,176104,377Aug 09 08:11 PM
WANG HUIMINCVP, Japan & IntercontinentalAug 09Sale115.546,350733,67998,027Aug 09 08:11 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAug 06Option Exercise21.7611,050240,44867,449Aug 06 07:10 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAug 06Sale114.3711,0501,263,76356,399Aug 06 07:10 PM
MUSSALLEM MICHAEL AChairman & CEOAug 03Option Exercise21.7645,050980,288233,052Aug 03 07:39 PM
MUSSALLEM MICHAEL AChairman & CEOAug 03Sale114.1432,5503,715,349188,002Aug 03 07:39 PM
Szyman Catherine M.CVP, Critical CareAug 02Option Exercise21.7615,000326,40042,759Aug 02 09:35 PM
Szyman Catherine M.CVP, Critical CareAug 02Sale113.5315,0001,702,90427,759Aug 02 09:35 PM
Wood Larry LCVP, TAVRJul 12Option Exercise35.207,830275,590379,964Jul 12 07:37 PM
Wood Larry LCVP, TAVRJul 12Sale107.487,830841,568372,134Jul 12 07:37 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJul 09Option Exercise21.7611,050240,44867,449Jul 09 09:47 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJul 09Sale108.1511,0501,195,11156,399Jul 09 09:47 PM
WANG HUIMINCVP, Japan & IntercontinentalJul 08Option Exercise21.766,350138,176104,377Jul 08 08:18 PM
WANG HUIMINCVP, Japan & IntercontinentalJul 08Sale106.726,350677,67298,027Jul 08 08:18 PM
WANG HUIMINCVP, Japan & IntercontinentalJun 15Option Exercise21.766,350138,176104,240Jun 15 08:33 PM
Szyman Catherine M.CVP, Critical CareJun 15Option Exercise22.293,41075,99831,115Jun 15 08:33 PM
WANG HUIMINCVP, Japan & IntercontinentalJun 15Sale101.006,350641,37097,890Jun 15 08:33 PM
Szyman Catherine M.CVP, Critical CareJun 15Sale101.173,410344,99027,705Jun 15 08:33 PM
Wood Larry LCVP, TAVRJun 14Option Exercise35.207,830275,590379,902Jun 14 09:21 PM
Chopra DaveenCVP, Surgical Structural HeartJun 14Option Exercise45.2824,0001,086,64139,827Jun 14 09:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJun 14Option Exercise21.7611,050240,44867,425Jun 14 09:21 PM
Wood Larry LCVP, TAVRJun 14Sale99.917,830782,295372,072Jun 14 09:21 PM
Chopra DaveenCVP, Surgical Structural HeartJun 14Sale99.9624,0002,398,99015,827Jun 14 09:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJun 14Sale99.8411,0501,103,20156,375Jun 14 09:21 PM
MUSSALLEM MICHAEL AChairman & CEOJun 09Option Exercise21.7645,050980,288233,052Jun 09 08:05 PM
MUSSALLEM MICHAEL AChairman & CEOJun 09Sale97.2332,5503,164,836188,002Jun 09 08:05 PM
Szyman Catherine M.CVP, Critical CareMay 28Sale95.292,061196,39327,705May 28 07:38 PM
Szyman Catherine M.CVP, Critical CareMay 25Sale96.094,665448,30029,766May 25 07:27 PM
MUSSALLEM MICHAEL AChairman & CEOMay 24Option Exercise21.7633,000718,080221,002May 25 07:26 PM
MUSSALLEM MICHAEL AChairman & CEOMay 24Sale95.6733,0003,156,991188,002May 25 07:26 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 17Option Exercise0.0017,193047,299May 19 04:30 PM
WANG HUIMINCVP, Japan & IntercontinentalMay 17Option Exercise0.008,6620103,123May 19 04:31 PM
Wood Larry LCVP, TAVRMay 17Option Exercise0.0016,4060381,979May 19 04:31 PM
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin AmerMay 17Option Exercise0.0010,6310152,828May 19 04:31 PM
MUSSALLEM MICHAEL AChairman & CEOMay 17Option Exercise0.0069,5620188,002May 19 04:30 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 17Option Exercise0.0015,750065,885May 19 04:30 PM
Wood Larry LCVP, TAVRMay 10Option Exercise35.207,830275,590375,509May 11 10:03 AM
Wood Larry LCVP, TAVRMay 10Sale92.227,830722,083367,679May 11 10:03 AM
Szyman Catherine M.CVP, Critical CareMay 07Option Exercise22.293,38975,53034,329May 07 06:32 PM
WANG HUIMINCVP, Japan & IntercontinentalMay 07Option Exercise21.766,350138,176102,263May 07 06:31 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 07Option Exercise21.7611,050240,44863,895May 07 06:32 PM
Szyman Catherine M.CVP, Critical CareMay 07Sale91.873,389311,34730,940May 07 06:32 PM
WANG HUIMINCVP, Japan & IntercontinentalMay 07Sale91.876,350583,37495,913May 07 06:31 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 07Sale92.5211,0501,022,33252,845May 07 06:32 PM
MUSSALLEM MICHAEL AChairman & CEOMay 05Option Exercise13.9865,550916,389162,565May 05 09:40 PM
MUSSALLEM MICHAEL AChairman & CEOMay 05Sale92.2835,5503,280,39497,015May 05 09:40 PM
STONE HEISZ LESLIEDirectorApr 23Option Exercise35.6810,000356,76729,272Apr 23 09:24 PM
SELLERS ROBERT W.A.VP, Corporate ControllerApr 23Sale97.6612,0001,171,97620,409Apr 23 09:26 PM
STONE HEISZ LESLIEDirectorApr 23Sale97.526,707654,06722,565Apr 23 09:24 PM
Szyman Catherine M.CVP, Critical CareApr 22Option Exercise22.293,38975,53030,355Apr 22 08:05 PM
Szyman Catherine M.CVP, Critical CareApr 22Sale94.403,389319,92226,966Apr 22 08:05 PM
Wood Larry LCVP, TAVRApr 12Option Exercise35.207,830275,590371,613Apr 12 06:52 PM
Wood Larry LCVP, TAVRApr 12Sale85.847,830672,108363,783Apr 12 06:52 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 09Option Exercise13.9813,077182,81661,922Apr 09 06:42 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 09Sale84.2713,0771,102,04648,845Apr 09 06:42 PM
MUSSALLEM MICHAEL AChairman & CEOApr 08Option Exercise13.9898,5501,377,729309,770Apr 08 08:57 PM
MUSSALLEM MICHAEL AChairman & CEOApr 08Sale84.4568,5505,789,048211,220Apr 08 08:57 PM
Szyman Catherine M.CVP, Critical CareMar 15Option Exercise22.293,38975,53030,135Mar 15 06:02 PM
Szyman Catherine M.CVP, Critical CareMar 15Sale81.663,389276,74626,746Mar 15 06:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 12Option Exercise13.9813,077182,81661,585Mar 12 07:52 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 12Sale82.8513,0771,083,37548,508Mar 12 07:52 PM
MUSSALLEM MICHAEL AChairman & CEOMar 09Option Exercise13.9898,5501,377,729309,770Mar 09 08:20 PM
MUSSALLEM MICHAEL AChairman & CEOMar 09Sale82.6668,5505,666,624211,220Mar 09 08:20 PM
WANG HUIMINCVP, Japan & IntercontinentalMar 08Option Exercise21.766,350138,17699,563Mar 08 08:06 PM
WANG HUIMINCVP, Japan & IntercontinentalMar 08Sale81.376,350516,70093,213Mar 08 08:06 PM
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin AmerMar 01Option Exercise13.9813,020182,020152,241Mar 01 08:15 PM
Wood Larry LCVP, TAVRMar 01Option Exercise35.207,830275,590371,313Mar 01 08:23 PM
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin AmerMar 01Sale84.7213,0201,103,063139,221Mar 01 08:15 PM
Wood Larry LCVP, TAVRMar 01Sale83.997,830657,642363,483Mar 01 08:23 PM
MUSSALLEM MICHAEL AChairman & CEOFeb 23Option Exercise13.9898,5501,377,729309,770Feb 23 09:36 PM
MUSSALLEM MICHAEL AChairman & CEOFeb 23Sale84.1768,5505,769,921241,220Feb 23 09:36 PM
Szyman Catherine M.CVP, Critical CareFeb 16Option Exercise22.293,38975,53030,135Feb 16 07:40 PM
Szyman Catherine M.CVP, Critical CareFeb 16Sale88.203,389298,91026,746Feb 16 07:40 PM
WANG HUIMINCVP, Japan & IntercontinentalFeb 11Option Exercise13.9811,661163,021104,958Feb 11 09:24 PM
WANG HUIMINCVP, Japan & IntercontinentalFeb 11Sale86.8111,7451,019,58393,213Feb 11 09:24 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 05Option Exercise13.9813,077182,81661,585Feb 05 08:13 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 05Sale85.8013,0771,121,99648,508Feb 05 08:13 PM
VALERIANI NICHOLAS JDirectorFeb 04Option Exercise20.7622,608469,30467,896Feb 05 06:21 PM